Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A stock index tracks a group of stocks to represent market performance, guiding benchmarks and passive investment strategies.
28,657 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Investors face a decisive choice: lean into specialized aerospace parts with HEICO or embrace Textron’s diversified i...
A director at AMN Healthcare recently disclosed selling about 3,681 shares for roughly $114,000 as the stock jumped 4...
When market turbulence rises, even growth-focused firms recalibrate. Francis Financial doubles down on fixed income, ...
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
A Warby Parker director recently sold 25,000 shares, triggering questions about insider moves. This article breaks do...
A quarterly filing may seem dry, but it can reveal game-changing shifts in ultra-wealthy portfolios. This article exp...
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
When prominent athletes face controversy, the financial implications go beyond contracts. This piece explores how Adr...
SoundHound AI trades in a fast-moving AI landscape with big growth potential and meaningful risks. This piece breaks ...
A sharp rally inAehr Test Systems has investors wondering what's next. This article breaks down the catalysts, the bu...